首页> 外文期刊>International Journal of Pharmaceutics >Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing.
【24h】

Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing.

机译:邻苯二甲酸二(2-乙基己基)酯和偏苯三酸三(2-乙基己基)酯从血液透析管中浸出性的比较研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The leachability of both Di(2-ethylhexyl) phthalate (DEHP) and Tri(2-ethylhexyl) trimellitate (TEHTM) or Trioctyl trimellitate (TOTM) from haemodialysis tubing was investigated in 20 patients with chronic renal failure undergoing maintenance haemodialysis. The blood tubing made of common polyvinyl chloride (PVC) plasticized with DEHP (group 1 patients) were replaced with tubing plasticized with TOTM-DEHP (group 2 patients). The patient blood obtained from the inlet and the outlet of the dialyzer was analyzed during a 4 h-dialysis session. Thus, the circulating concentrations of both DEHP and TOTM resulting from the release from dialyzer tubes were estimated using High-performance Liquid chromatograph (HPLC). With the common PVC-DEHP blood tubing, a DEHP quantity of 122.95+/-33.94 mg was extracted from tubing during a single dialysis session (ranging from 55 to 166.21 mg). During the same period, the total amounts of DEHP retained by the patients were 27.30+/-9.22 mg (ranging from 12.50 to 42.72 mg). As for blood tubing plasticized with TOTM-DEHP, 41.80+/-4.47 mg of DEHP and 75.11+/-25.72 mg of TOTM were extracted. During the same period, the amounts of DEHP and TOTM retained by the patients were 3.42+/-1.37 mg and 4.87+/-2.60 mg, respectively. The extraction rate both plasticizers was correlated with serum lipid content (cholesterol+triglyceride) (r(2)=0.75 for DEHP and r(2)=0.64 for TOTM). In the present investigation, less TOTM and DEHP were apparently released from haemodialysis tubing plasticized with TOTM-DEHP than DEHP released from haemodialysis tubing plasticized with DEHP only. TOTM seems to be a superior alternative to DEHP for use in medical devices because of its potential lower leachability. To recommend it as an alternative plasticizer, its possible toxicity towards human body should be investigated before it can be used routinely. However, patients undergoing haemodialysis using tubing plasticized with DEHP only are regularly exposed to non negligible amounts of DEHP. In view of several biological effects previously reported, it is time to reconsider the use of DEHP only as a plasticizer.
机译:在20例接受维持性血液透析的慢性肾功能衰竭患者中,研究了邻苯二甲酸二(2-乙基己基)苯三酸酯(DEHP)和偏苯三酸三(2-乙基己基)苯三酸酯(TEHTM)或偏苯三酸三辛酯(TOTM)的浸出性。由用DEHP增塑的普通聚氯乙烯(PVC)制成的血液导管(第1组患者)被用TOTM-DEHP增塑的血液导管(第2组患者)代替。在4小时的透析过程中分析了从透析器的入口和出口获得的患者血液。因此,使用高效液相色谱仪(HPLC)估算了从透析管释放所产生的DEHP和TOTM的循环浓度。使用普通的PVC-DEHP输液管,在一次透析过程中(从55到166.21 mg)从管中提取出DEHP量为122.95 +/- 33.94 mg。在同一时期,患者保留的DEHP总量为27.30 +/- 9.22 mg(范围从12.50至42.72 mg)。至于用TOTM-DEHP塑化的血液管,提取了41.80 +/- 4.47 mg的DEHP和75.11 +/- 25.72 mg的TOTM。在同一时期,患者保留的DEHP和TOTM量分别为3.42 +/- 1.37 mg和4.87 +/- 2.60 mg。两种增塑剂的提取率均与血清脂质含量(胆固醇+甘油三酸酯)相关(DEHP的r(2)= 0.75,TOTM的r(2)= 0.64)。在本研究中,与仅用DEHP塑化的血液透析管释放的DEHP相比,用TOTM-DEHP塑化的血液透析管释放的TOTM和DEHP明显更少。 TOTM似乎是DEHP在医疗设备中的替代品,因为它潜在的较低浸出性。为了推荐它作为替代增塑剂,应在常规使用前研究其可能对人体的毒性。但是,仅使用增塑有DEHP的管道进行血液透析的患者应定期暴露于不可忽略的DEHP量。鉴于先前报道的几种生物效应,现在是时候重新考虑仅将DEHP用作增塑剂了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号